Polycystic Ovarian Syndrome Treatment Market, By Drug Type (Oral Contraceptives, Antiandrogens, Insulin-Sensitizing Agent, Anti-Obesity Drugs and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies) and By Region - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2018-2026

  • To Be Published : Jul 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Polycystic ovary syndrome is reproductive disorder observed during reproductive age of females. Polycystic ovarian syndrome is depicted by hyperandrogenism, polycystic ovaries and anovulation. There is no cure for polycystic ovarian syndrome. Medical treatments aim to manage and reduce the symptoms or consequences of having polycystic ovarian syndrome with medication for menstrual cycle regulation, infertility treatment, insulin resistance treatment, weight loss treatment and hyperandrogenism. Polycystic ovarian syndrome occurs both in normal-weight and overweight women. However, factors such as insulin resistance (IR), type 2 diabetes, obesity, and cardiovascular disease enhances the chances of polycystic ovarian syndrome occurrence. The factors driving polycystic ovarian syndrome treatment market are increasing funds and grants for research for novel treatment, increasing product approval and pipeline candidates, disease prevalence and high prevalence of risk prone population.

Polycystic Ovarian Syndrome Treatment Market – Driver

The organic and inorganic strategies by the market players will boost the polycystic ovarian syndrome treatment market. For instance, in 2016, Millendo Therapeutics, Inc., a biopharmaceutical company, entered into an exclusive license agreement with AstraZeneca for the development and commercialization of phase II entered AZD4901, a candidate product for the treatment of polycystic ovarian syndrome. Moreover, in 2017, Astellas Pharma Inc. completed its acquisition of Ogeda SA (formerly Euroscreen S.A.). The acquisition will expand Astellas’ clinical pipeline with fezolinetant, oral compaound for NK3 receptor target. Fezolinetant was in phase IIa clinical trials for the  treatment of menopausal hot flashes, polycystic ovary syndrome (PCOS) and uterine fibroids. Moreover, product approval by various approval bodies will expand the treatment option and in turn leading to the market growth. For instance, in 2014, EffRx Pharmaceuticals SA, got US FDA approval for its proprietary metformin-based product candidate, EX404, for pediatric polycystic ovary syndrome (PCOS).

Increasing funding for research and development of novel treatment will also enhance the polycystic ovarian syndrome treatment market during the forecast period. For instance, in 2017, Bayer and the Society for Reproductive Investigation (SRI) launched of the SRI-Bayer Discovery and Innovation Grants Program for supporting research initiatives for addressing unmet medical needs in women’s health. The grant is dedicated to research in endometriois, uterine fibroids and polycystic ovarian syndrome. Further, grants for the treatment of polycystic ovarian syndrome will fuel the market growth. For instance, in 2017, as part of a multi-year endowment from PCOS Diva, the nonprofit organization PCOS Challenge, Inc. will be offering grants up to $500 to help women and girls struggling with hair and skin issues related to polycystic ovary syndrome (PCOS).

High incidence of polycystic ovarian syndrome is expected to be the key driver for the polycystic ovarian syndrome treatment market. For instance, according to article published in 2014 of Clinical Epidemiology, polycystic ovarian syndrome affects 8 – 20 % of the reproductive-age women, globally. According to World Health Organization, in year 2012 the estimated number of polycystic ovarian syndrome is 116 million worldwide.

Moreover, increasing prevalence of insulin resistance (IR), type 2 diabetes, obesity, and cardiovascular disease fuel the polycystic ovarian syndrome market. According to article published in Lancet, globally, prevalence of overweight and obesity combined has risen by 27.5% for adults between 1980 and 2013.  Moreover, according to data by the National Health and Nutrition Examination Survey (NHANES), 2013–2014, in the United States the percentage of obesity is higher in women, i.e. 40 %, than in men, 35%.

Polycystic Ovarian Syndrome Treatment Market – Restrain

The global polycystic ovarian syndrome treatment market growth is hampered by off-labelled and generic drugs present in the market. Moreover, the market is also hindered by the alternated treatment such as used of surgical procedures such as ovarian drilling and laparoscopic drilling.

Polycystic Ovarian Syndrome Treatment Market - Regional Analysis

Regional segmentation of polycystic ovarian syndrome treatment market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America market is expected to emerge as the dominant market for polycystic ovary syndrome treatment market owing to a high diagnosis rate, larger number of local players such as AstraZeneca, Teva etc. and high prevalence of the polycystic ovarian syndrome in the region. Asia Pacific is expected to witness fast growth during the forecast period attributing to high population of risk prone individuals.

Polycystic Ovarian Syndrome Treatment Market – Competitor

The key player involved in the polycystic ovarian syndrome treatment market are Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Ltd.), Teva Pharmaceutical Industries Ltd., Eisai Pharmaceuticals India Pvt. Ltd (EIL), VIVUS, Inc., SkinMedica, Inc. (part of Allergan, Inc.), Ferring Pharmaceuticals Inc., AstraZeneca plc and EffRx, Inc.

Polycystic Ovarian Syndrome Treatment Market - Taxonomy

By Drug Type

  • Oral Contraceptives
    • Menopur
    • Bravelle
    • Other Oral Contraceptives
  • Antiandrogens
  • Insulin-sensitizing Agent
    • Pioglitazone
    • Rosiglitazone
    • Other Insulin-sensitizing Agents
  • Anti-obesity Drugs
    • Xenical
    • Qsymia
    • Belviq
    • Other Anti-Obesity Drugs
  • Other

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.